Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
公司代碼CYRX
公司名稱Cryoport Inc
上市日期Jul 24, 2015
CEOShelton (Jerrell Wilson)
員工數量1090
證券類型Ordinary Share
年結日Jul 24
公司地址112 Westwood Place, Suite 350
城市BRENTWOOD
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編37027
電話19492321900
網址https://www.cryoport.com/
公司代碼CYRX
上市日期Jul 24, 2015
CEOShelton (Jerrell Wilson)